ORGO: Organogenesis Holdings Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Organogenesis Holdings Inc (ORGO).

OverviewDividends

$424.24M Market Cap.

As of 05/09/2025 5:00 PM ET (MRY) • Disclaimer

ORGO Market Cap. (MRY)


ORGO Shares Outstanding (MRY)


ORGO Assets (MRY)


Total Assets

$497.89M

Total Liabilities

$112.57M

Total Investments

$0

ORGO Income (MRY)


Revenue

$482.04M

Net Income

$861.00K

Operating Expense

$367.56M

ORGO Cash Flow (MRY)


CF Operations

$14.21M

CF Investing

-$10.03M

CF Financing

$27.64M

ORGO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$497,886,000 (8.23%)

$460,025,000 (2.37%)

$449,359,000 (1.38%)

$443,259,000 (52.73%)

Assets Current

$285,941,000 (27.06%)

$225,044,000 (1.09%)

$222,609,000 (-1.93%)

$226,979,000 (30.19%)

Assets Non-Current

$211,945,000 (-9.80%)

$234,981,000 (3.63%)

$226,750,000 (4.84%)

$216,280,000 (86.65%)

Goodwill & Intangible Assets

$41,240,000 (-7.62%)

$44,643,000 (-9.92%)

$49,561,000 (-8.97%)

$54,445,000 (-8.33%)

Shareholders Equity

$262,897,000 (-5.66%)

$278,663,000 (4.89%)

$265,669,000 (10.08%)

$241,335,000 (70.18%)

Property Plant & Equipment Net

$126,238,000 (-19.26%)

$156,346,000 (7.34%)

$145,655,000 (13.52%)

$128,304,000 (129.97%)

Cash & Equivalents

$136,151,000 (30.49%)

$104,338,000 (1.01%)

$103,290,000 (-9.81%)

$114,528,000 (35.05%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$26,219,000 (-7.20%)

$28,253,000 (14.00%)

$24,783,000 (-0.96%)

$25,022,000 (-9.99%)

Trade & Non-Trade Receivables

$109,861,000 (33.98%)

$81,999,000 (-8.33%)

$89,450,000 (8.48%)

$82,460,000 (45.17%)

Trade & Non-Trade Payables

$28,911,000 (-5.90%)

$30,724,000 (-4.97%)

$32,330,000 (10.19%)

$29,339,000 (25.48%)

Accumulated Retained Earnings (Deficit)

-$40,110,000 (2.10%)

-$40,971,000 (9.56%)

-$45,301,000 (25.53%)

-$60,833,000 (60.76%)

Tax Assets

$39,462,000 (40.93%)

$28,002,000 (-6.70%)

$30,014,000 (-6.19%)

$31,994,000 (177644.44%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$43,312,000 (-63.71%)

$119,351,000 (-3.59%)

$123,791,000 (-6.43%)

$132,303,000 (56.07%)

Debt Current

$9,113,000 (-53.77%)

$19,711,000 (21.33%)

$16,246,000 (10.96%)

$14,641,000 (-27.82%)

Debt Non-Current

$34,199,000 (-65.68%)

$99,640,000 (-7.35%)

$107,545,000 (-8.60%)

$117,662,000 (82.46%)

Total Liabilities

$112,570,000 (-37.93%)

$181,362,000 (-1.27%)

$183,690,000 (-9.03%)

$201,924,000 (36.06%)

Liabilities Current

$77,477,000 (-3.77%)

$80,509,000 (7.31%)

$75,023,000 (-9.29%)

$82,705,000 (21.24%)

Liabilities Non-Current

$35,093,000 (-65.20%)

$100,853,000 (-7.19%)

$108,667,000 (-8.85%)

$119,219,000 (48.67%)

ORGO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$482,043,000 (11.29%)

$433,140,000 (-3.94%)

$450,893,000 (-3.52%)

$467,359,000 (38.15%)

Cost of Revenue

$115,741,000 (8.70%)

$106,481,000 (1.39%)

$105,019,000 (-8.04%)

$114,199,000 (30.78%)

Selling General & Administrative Expense

$294,513,000 (9.18%)

$269,754,000 (-4.95%)

$283,808,000 (13.43%)

$250,200,000 (22.53%)

Research & Development Expense

$50,271,000 (13.27%)

$44,380,000 (11.61%)

$39,762,000 (29.34%)

$30,742,000 (53.05%)

Operating Expenses

$367,565,000 (17.03%)

$314,077,000 (-2.94%)

$323,583,000 (15.18%)

$280,942,000 (25.26%)

Interest Expense

$1,544,000 (-29.50%)

$2,190,000 (9.01%)

$2,009,000 (-72.24%)

$7,236,000 (-35.85%)

Income Tax Expense

-$3,668,000 (-167.34%)

$5,447,000 (14.67%)

$4,750,000 (115.27%)

-$31,116,000 (-5970.94%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$861,000 (-82.59%)

$4,945,000 (-68.16%)

$15,532,000 (-83.51%)

$94,202,000 (446.61%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$861,000 (-82.59%)

$4,945,000 (-68.16%)

$15,532,000 (-83.51%)

$94,202,000 (446.61%)

Preferred Dividends Income Statement Impact

$1,798,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$937,000 (-118.95%)

$4,945,000 (-68.16%)

$15,532,000 (-83.51%)

$94,202,000 (446.61%)

Weighted Average Shares

$131,673,278 (0.34%)

$131,231,317 (0.89%)

$130,070,231 (1.36%)

$128,331,022 (19.11%)

Weighted Average Shares Diluted

$131,673,278 (-0.81%)

$132,746,727 (0.27%)

$132,383,152 (-0.96%)

$133,662,659 (20.03%)

Earning Before Interest & Taxes (EBIT)

-$1,263,000 (-110.04%)

$12,582,000 (-43.56%)

$22,291,000 (-68.30%)

$70,322,000 (142.13%)

Gross Profit

$366,302,000 (12.14%)

$326,659,000 (-5.56%)

$345,874,000 (-2.06%)

$353,160,000 (40.71%)

Operating Income

-$1,263,000 (-110.04%)

$12,582,000 (-43.56%)

$22,291,000 (-69.13%)

$72,218,000 (170.48%)

ORGO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$10,032,000 (58.82%)

-$24,364,000 (28.13%)

-$33,898,000 (-8.58%)

-$31,220,000 (-32.86%)

Net Cash Flow from Financing

$27,637,000 (602.03%)

-$5,505,000 (-150.34%)

-$2,199,000 (-112.26%)

-$1,036,000 (-102.44%)

Net Cash Flow from Operations

$14,208,000 (-54.04%)

$30,917,000 (24.37%)

$24,859,000 (-59.89%)

$61,978,000 (1033.88%)

Net Cash Flow / Change in Cash & Cash Equivalents

$31,813,000 (2935.59%)

$1,048,000 (109.33%)

-$11,238,000 (-137.81%)

$29,722,000 (21.63%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$10,032,000 (58.82%)

-$24,364,000 (28.13%)

-$33,898,000 (-8.58%)

-$31,220,000 (-76.60%)

Issuance (Repayment) of Debt Securities

-$67,644,000 (-1207.64%)

-$5,173,000 (-71.69%)

-$3,013,000 (-49.60%)

-$2,014,000 (87.34%)

Issuance (Purchase) of Equity Shares

-$24,232,000 (0%)

$0 (0%)

$2,070,000 (-5.82%)

$2,198,000 (-96.45%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$10,578,000 (17.59%)

$8,996,000 (37.30%)

$6,552,000 (69.57%)

$3,864,000 (132.63%)

Depreciation Amortization & Accretion

$25,374,000 (8.21%)

$23,449,000 (30.05%)

$18,031,000 (8.13%)

$16,676,000 (103.79%)

ORGO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

76.00% (0.80%)

75.40% (-1.69%)

76.70% (1.46%)

75.60% (1.89%)

Profit Margin

-0.20% (-118.18%)

1.10% (-67.65%)

3.40% (-83.17%)

20.20% (296.08%)

EBITDA Margin

5.00% (-39.76%)

8.30% (-6.74%)

8.90% (-52.15%)

18.60% (69.09%)

Return on Average Equity (ROAE)

-0.30% (-116.67%)

1.80% (-70.49%)

6.10% (-87.58%)

49.10% (102.06%)

Return on Average Assets (ROAA)

-0.20% (-118.18%)

1.10% (-68.57%)

3.50% (-86.17%)

25.30% (251.39%)

Return on Sales (ROS)

-0.30% (-110.34%)

2.90% (-40.82%)

4.90% (-67.33%)

15.00% (74.42%)

Return on Invested Capital (ROIC)

-0.40% (-111.43%)

3.50% (-46.97%)

6.60% (-76.26%)

27.80% (70.55%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-320 (-412.96%)

102.25 (356.13%)

22.42 (77.10%)

12.66 (-73.10%)

Price to Sales Ratio (P/S)

0.87 (-29.46%)

1.24 (59.66%)

0.78 (-69.41%)

2.54 (5.80%)

Price to Book Ratio (P/B)

1.61 (-16.72%)

1.94 (46.15%)

1.33 (-73.08%)

4.92 (-13.94%)

Debt to Equity Ratio (D/E)

0.43 (-34.25%)

0.65 (-5.79%)

0.69 (-17.44%)

0.84 (-20.06%)

Earnings Per Share (EPS)

-0.01 (-125.00%)

0.04 (-66.67%)

0.12 (-83.56%)

0.73 (356.25%)

Sales Per Share (SPS)

3.66 (10.91%)

3.3 (-4.79%)

3.47 (-4.81%)

3.64 (15.99%)

Free Cash Flow Per Share (FCFPS)

0.03 (-36.00%)

0.05 (172.46%)

-0.07 (-128.75%)

0.24 (312.39%)

Book Value Per Share (BVPS)

2 (-5.93%)

2.12 (3.92%)

2.04 (8.61%)

1.88 (42.93%)

Tangible Assets Book Value Per Share (TABVPS)

3.47 (9.57%)

3.17 (2.96%)

3.07 (1.45%)

3.03 (41.46%)

Enterprise Value Over EBIT (EV/EBIT)

-345 (-866.67%)

45 (164.71%)

17 (0.00%)

17 (-45.16%)

Enterprise Value Over EBITDA (EV/EBITDA)

18.07 (15.44%)

15.65 (69.73%)

9.22 (-33.03%)

13.77 (-42.37%)

Asset Turnover

1.04 (9.77%)

0.95 (-4.99%)

1 (-20.22%)

1.26 (-10.73%)

Current Ratio

3.69 (32.06%)

2.79 (-5.80%)

2.97 (8.13%)

2.74 (7.36%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$4,176,000 (-36.27%)

$6,553,000 (172.50%)

-$9,039,000 (-129.39%)

$30,758,000 (351.87%)

Enterprise Value (EV)

$435,701,806 (-22.75%)

$564,037,361 (51.67%)

$371,880,616 (-68.96%)

$1,198,010,643 (34.69%)

Earnings Before Tax (EBT)

-$2,807,000 (-127.01%)

$10,392,000 (-48.76%)

$20,282,000 (-67.85%)

$63,086,000 (255.13%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$24,111,000 (-33.08%)

$36,031,000 (-10.64%)

$40,322,000 (-53.65%)

$86,998,000 (133.70%)

Invested Capital

$286,330,000 (-18.16%)

$349,886,000 (1.34%)

$345,276,000 (6.60%)

$323,884,000 (99.22%)

Working Capital

$208,464,000 (44.23%)

$144,535,000 (-2.07%)

$147,586,000 (2.30%)

$144,274,000 (35.94%)

Tangible Asset Value

$456,646,000 (9.93%)

$415,382,000 (3.90%)

$399,798,000 (2.83%)

$388,814,000 (68.45%)

Market Capitalization

$424,244,806 (-21.44%)

$540,048,361 (53.35%)

$352,161,616 (-70.37%)

$1,188,648,643 (46.45%)

Average Equity

$270,743,750 (-0.69%)

$272,627,750 (6.95%)

$254,902,500 (32.98%)

$191,680,750 (170.61%)

Average Assets

$461,456,500 (1.47%)

$454,773,000 (1.10%)

$449,815,000 (20.88%)

$372,106,750 (54.81%)

Invested Capital Average

$329,645,250 (-7.58%)

$356,680,000 (6.35%)

$335,369,000 (32.66%)

$252,811,250 (42.22%)

Shares

132,576,502 (0.41%)

132,041,164 (0.86%)

130,915,099 (1.77%)

128,641,628 (19.35%)